STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$297,802
-28.4%
65,451
+10.8%
0.00%0.0%
Q2 2023$415,789
+40.9%
59,061
+22.3%
0.00%0.0%
Q1 2023$295,180
-4.4%
48,3110.0%0.00%0.0%
Q4 2022$308,707
-40.5%
48,311
-10.8%
0.00%0.0%
Q3 2022$519,000
-13.2%
54,1310.0%0.00%0.0%
Q2 2022$598,000
-82.9%
54,131
-74.2%
0.00%
-85.7%
Q1 2022$3,490,000
-12.7%
209,602
+0.1%
0.01%0.0%
Q4 2021$3,998,000
-22.5%
209,449
+0.2%
0.01%
-30.0%
Q3 2021$5,157,000
-7.6%
209,128
-2.5%
0.01%
-9.1%
Q2 2021$5,582,000
+7.4%
214,526
+30.7%
0.01%
+10.0%
Q1 2021$5,197,000
-32.8%
164,138
-1.5%
0.01%
-37.5%
Q4 2020$7,731,000
+41.6%
166,618
+0.5%
0.02%
+33.3%
Q3 2020$5,458,000
+21.2%
165,805
+1.1%
0.01%
+9.1%
Q2 2020$4,503,000
+206.5%
164,035
+234.3%
0.01%
+175.0%
Q1 2020$1,469,000
+29.5%
49,072
+19.7%
0.00%
+33.3%
Q4 2019$1,134,000
+62.7%
40,982
+7.0%
0.00%
+50.0%
Q3 2019$697,000
-25.8%
38,3120.0%0.00%0.0%
Q2 2019$939,000
+205.9%
38,312
+18.8%
0.00%
+100.0%
Q1 2019$307,000
+7.3%
32,2620.0%0.00%0.0%
Q4 2018$286,000
-11.2%
32,262
+12.8%
0.00%0.0%
Q3 2018$322,000
+8.1%
28,612
+22.8%
0.00%0.0%
Q2 2018$298,000
+20.6%
23,292
+59.2%
0.00%0.0%
Q1 2018$247,00014,6320.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 12,201,261$203,150,0004.07%
Paradigm Biocapital Advisors LP 907,428$15,109,0004.00%
Avoro Capital Advisors LLC 9,125,000$151,931,0002.77%
Logos Global Management LP 1,000,000$16,650,0002.16%
Avidity Partners Management LP 6,043,219$100,620,0002.10%
Orbimed Advisors 6,633,006$110,440,0001.79%
Parametrica Management Ltd 134,679$2,240,0001.66%
Boxer Capital, LLC 1,935,133$32,220,0001.66%
Fairmount Funds Management LLC 389,588$6,487,0001.53%
Long Focus Capital Management, LLC 705,000$11,738,0001.51%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders